Hisun Pharm Hangzhou's Generic Capreomycin Sulfate Receives Approval in US
MUMBAI: Ahead of the first-ever United Nations High level Meeting next month, the World Health Organisation on Friday announced crucial changes to the multi drug resistant TB treatment regimen, which includes expanding the usage of the latest tuberculosis drug, Bedaquiline. It also calls on countries to minimize the use of injectibles, which are known to cause serious side effects in patients.
Zydus Pharm’s Generic Candesartan Cilexetil; Hydrochlorothiazide Receives Approval In US
Says Dr Harshdeep Kamble, Maharashtra FDA Commissioner, “The state regulator is planning a major drive to detect spurious drugs in the aftermath of rampant violations of good manufacturing practices (GMPs) by drug manufacturers. Around 12 pharma manufacturers have been identified and investigations are going on to ensure that there is no circulation of spurious drugs in domestic market and outside the country. It was observed that the label claims stated on various manufactured drugs are not in accordance with the formula approved by the State Licensing Authority.
Zhejiang Hisun Pharmaceutical, Co., Ltd. (Yantou Campus) Fails EDQM Inspection
On May 10, 2016, the World Health Organization’s Prequalification Team added Macleods Pharmaceuticals Limited’s TB drug Capreomycin (as Sulfate) 1g Powder for Injection to its Prequalified List. The product will be manufactured at the company’s Kachigam, Daman, India facility.